Search
Powered By HealthLine
Special Offers
Health Tools
 Depression Basics
 Antidepressant Drug Info
 Depression Q&A
 Depression Support Groups
 Depression Related Disorders
Featured Conditions
 Depression
 Anxiety
 Sleep
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Scientists Spot Biochemical Sign of Depression

Could lead to quick blood test that would show whether an antidepressant is working

By Randy Dotinga
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
Autism
Bell's Palsy
Bipolar Disorder
More...

Related Healthscout Videos
 border=
Body Dysmorphic Disorder- A Serious Disease
New Drugs That Could Stop MS
New Therapy for Stroke Patients
Meet Sue Bergeson
More...

Related Animations
 border=
Bipolar Disorder Animation
Depression
More...

Related Drug Information
 border=
Adderal XR
Ambien
Avandia
Concerta
More...

Related News Articles
 border=
Gene Variant Tied to Cocaine-Induced Paranoia
Kids' Risks Increase When Parents Are Bipolar
Media Images of Alcohol Can Drive You to Drink
Brain Adapts to Age-Related Eye Disease
More...

TUESDAY, March 11 (HealthDay News) -- Researchers say they've discovered a biomarker for depression that could lead to a quick lab test to determine whether a particular antidepressant is making headway against the disease.

"This may be a very simple biochemical indicator for depression," said study co-author Mark Rasenick, director of the Interdisciplinary Neuroscience Program at the University of Illinois at Chicago. The test "wouldn't tell you which [medication] to start, but it would tell you if the one you're taking is working."

Text Continues Below



It may even be possible to use the test to determine whether rounds of psychotherapy are reaping any benefit, he said.

For now, however, such a test is a hypothetical, pending further exploration of the finding reported in the March edition of The Journal of Neuroscience.

At issue is whether the brain itself shows physical or chemical signs of depression.

The researchers looked at the interaction of neurotransmitters and a protein called Gs alpha. In brain cells, the protein acts like a kind of butler, passing messages from neurotransmitters on the outside and amplifying their messages, Rasenick explained.

When the protein is working properly, it's like a butler whose "hands are just flying, cooking and cleaning at the same time," he said. But when the brain is depressed, "it just sits there in the corner."

In this post-mortem study, the researchers looked at the protein in the brains of 18 depressed people who committed suicide and compared them to the brains of non-depressed people. They found the protein would have worked less effectively in the brain cells of the suicide victims.

The findings raise the prospect of a blood test that would measure within days whether antidepressants are effectively treating depression, Rasenick said.

Now, it can take several weeks for patients and psychiatrists to figure out if an antidepressant is working properly. According to Rasenick, only about 30 percent of depression patients will respond to a specific drug.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 3/12/2008

Related Links
 border=
From Healthscout's partner site on depression, MyDepressionConnection.com
UNDERSTAND: Get a full understanding of depression
TREATMENT: Learn how therapy and lifestyle changes can help
DRUGS: Common drugs used to treat depression





SOURCES: Mark Rasenick, Ph.D., distinguished university professor, physiology and biophysics and psychiatry, and director, Interdisciplinary Neuroscience Program, University of Illinois at Chicago; Gregory Simon, M.D., M.P.H., psychiatrist and mental health researcher, Group Health Cooperative, Seattle; March 2008, The Journal of Neuroscience


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map